A pharmaceutical composition comprising orlistat

PK140324AUndetermined Publication Date: 2009-11-25F HOFFMANN LA ROCHE & CO AG
0 Cites 0 Cited by

Patent Information

Application Number
PK200200484
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-11-25
Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition comprising a lipase inhibitor, preferably orlistat, having a melting point Z 37oC, a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di, tri-or tetra-ester, and optionally one or more pharmaceutically acceptable excipients.
Need to check novelty before this filing date? Find Prior Art